Stock Ratings / Health Care / NAII / earnings

BON (45) MTEX (33) AKAN (54) IMCC (64) ⌘ Pro Terminal →

Natural Alternatives International Inc. (NAII) Next Earnings Date & Expected ±12.5% Move

Q: Is NAII stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Natural Alternatives International Inc. (NASDAQ: NAII) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 34/100 at a spot price of $1.11 (-4.31% 1D, market cap $6.9M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 4/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, NAII ranks #855 in composite RQD confidence.

Q: How does NAII compare to BON and MTEX in the Health Care sector?

Within the Health Care sector (Medicinal Chemicals and Botanical Products), NAII carries a Roarable E (34/100 RQD), trailing P/E of N/A, gross margin of 7.2%, and ROIC of -10.8%. By comparison, BON (Bon Natural Life Limited (Class A)) holds a D grade (45/100 RQD, P/E N/A, ROIC —, cap $9.2M) and MTEX (Mannatech Incorporated) posts a E grade (33/100 RQD, P/E N/A, ROIC -35.0%, cap $16.1M). Among the 5-stock peer group, NAII leads on earnings multiple (N/A) while NAII leads on capital efficiency (-10.8% ROIC).

Q: What are the biggest fundamental strengths and SEC risk factors for NAII?

Per NAII's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0000787253), Natural Alternatives International Inc. generated $129.9M in revenue (+14.1% YoY), -$13.6M in net income, and $2.3M in free cash flow against $153.3M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Q: Where is NAII trading relative to its 50-day, 200-day, and 52-week technical levels?

NAII last traded at $1.11 (-4.31% on volume of 38,016 shares), positioning the stock -31.90% below its 50-day simple moving average ($1.63) and -54.69% below its 200-day simple moving average ($2.45). Across its 52-week range of $1.07 to $4.96, NAII sits at the 1.0% percentile with a 14-day RSI of 25.4 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.00 to $1.25).

Q: When is NAII's next earnings date?

Based on SEC filing cadence, Natural Alternatives International Inc. (NAII)'s next quarterly reporting window is estimated around Dec 28, 2026.

Q: How much is NAII stock expected to move on earnings?

Volatility modeling currently projects a ±12.5% event move for NAII, spanning a range between $1 and $1.25.

$1.11 -4.31% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.10

Natural Alternatives International Inc. (NAII) carries a Roarable Rating of E (Strong Sell) with 34/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (34/100 · E) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE E • RED ALERT Cap $6.9M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $1.10 (-0.97%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 9/20 (D) • 1.8% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (34/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-8.7% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D-

Each axis scored 0–20

12M PRICE TARGET CONE-10.8% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for NAII)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (34/100 Composite)

🔍 WHY NAII SCORES 34/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Cash Engine Quality+9/20 pts (26% of score)

SEC XBRL FY 2025 (10-K): 1.8% FCF Margin ($2.3M FCF) & 7.2% Gross Margin

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (24% of score)

Altman Z-Score 1.45 (DISTRESS RISK (<1.8)) • Piotroski F-Score 4/9

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$1.14+0.9% Next Q

Q2 (-2Q)

Grade E$1.15+5.2% Next Q

Q3 (-1Q)

Grade E$1.21-8.3% Next Q

Current

Grade E$1.11-8.7% Hist 90D α

Trajectory: D (42) → E (34)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a NAII Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While NAII currently carries a cautious 34/100 (E) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.63) and Max Pain ($1.17) forces dealer call-delta covering toward $5.21.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $NAII• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “NAII Beats Next Quarter EPS Consensus (Dec 28, 2026) & Holds Above 200D SMA”

YES 34%NO 66%Trade / Inspect Odds →

NEXT EST. WINDOW: Dec 28, 2026 (~56 DAYS)

Historical OHLCV Volatility ±12.5% Swing Band

±$0.14 Expected Swing

MODEL EARNINGS SETUP GAUGE

NAII Quantitative Pre-Earnings Setup: 34/100

Trailing EPS: $4.25 • YoY Revenue Growth: 12.4%

Model Bullish Setup (34/100)Model Risk Weight (66/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

Period	Filed	Revenue	Net Profit	Free Cash Flow	Gross Margin
FY 2025	2025-06-30	$129.9M	-$13.6M	$2.3M	7.2%
FY 2024	2024-06-30	$113.8M	-$7.2M	-$4.5M	6%
FY 2023	2023-06-30	$0	$2.5M	$7.0M	8%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring NAII)

✓Walkthrough of NAII's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

NAII // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -58.43%▼ DESCENDING CHANNEL

2026-10-30O $1.13H $1.13L $1.07C $1.11VOL 2.7K

RES: $2.08SUP: $0.90SMA50: $1.63SMA200: $2.45

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

NAII Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 NAII Butterfly Map → + Track NAII →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on NAII today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for NAII. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for NAII today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NAII)

Health Care Rank #855 of 1016 ⚔️ BON vs NAII Full Matrix →

1. Head-to-Head Health Care Peer Comparison (NAII vs. BON, MTEX, AKAN, IMCC)

Industry: Medicinal Chemicals and Botanical Products (24 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Natural Alternatives International Inc. (NAII) ranks #855 by composite RQD confidence (34/100, grade E) and #922 by equity capitalization ($6.9M). Within this direct 5-issuer industry benchmark cohort, NAII leads on earnings valuation at N/A trailing P/E, while NAII leads on capital efficiency and profitability with -10.8% ROIC and 7.2% gross margin. IMCC currently holds the highest overall quantitative score in the immediate peer group at 64/100 (C) compared with NAII at 34/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
NAII ACTIVE Natural Alternatives International Inc.	E	34/100	—	7.2%	-10.8%	-4.31%	$6.9M	Benchmark Subject
BON Bon Natural Life Limited (Class A)	D	45/100	—	20.8%	—	-0.01%	$9.2M	/bon-vs-naii →
MTEX Mannatech Incorporated	E	33/100	—	74.9%	-35.0%	-2.23%	$16.1M	/mtex-vs-naii →
AKAN Akanda Corp.	D+	54/100	—	—	—	+2.80%	$2.6M	/akan-vs-naii →
IMCC IM Cannabis Corp.	C	64/100	—	—	—	+3.53%	$1.5M	/imcc-vs-naii →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-06-30 • CIK 0000787253

In its most recent audited fiscal period (FY2025, filed 2025-06-30), Natural Alternatives International Inc. (NAII) reported GAAP revenue of $129.9M (+14.1% vs. FY2024 revenue of $113.8M ) , GAAP net income of -$13.6M, operating cash flow of $5.9M, and free cash flow of $2.3M (+151.4% YoY). On the balance sheet, NAII closed FY2025 with $153.3M in total assets against $0 in total debt (Altman Z-Score: 1.45, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-06-30	$129.9M	-$13.6M	$5.9M	$2.3M	$153.3M	—
FY2024 (FY)	2024-06-30	$113.8M	-$7.2M	-$1.5M	-$4.5M	$156.1M	—
FY2023 (FY)	2023-06-30	$0	$2.5M	$7.0M	$7.0M	—	—

3. NAII Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is NAII stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Natural Alternatives International Inc. (NASDAQ: NAII) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 34/100 at a spot price of $1.11 (-4.31% 1D, market cap $6.9M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 4/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, NAII ranks #855 in composite RQD confidence.

How does NAII compare to BON and MTEX in the Health Care sector?

Within the Health Care sector (Medicinal Chemicals and Botanical Products), NAII carries a Roarable E (34/100 RQD), trailing P/E of N/A, gross margin of 7.2%, and ROIC of -10.8%. By comparison, BON (Bon Natural Life Limited (Class A)) holds a D grade (45/100 RQD, P/E N/A, ROIC —, cap $9.2M) and MTEX (Mannatech Incorporated) posts a E grade (33/100 RQD, P/E N/A, ROIC -35.0%, cap $16.1M). Among the 5-stock peer group, NAII leads on earnings multiple (N/A) while NAII leads on capital efficiency (-10.8% ROIC).

What are the biggest fundamental strengths and SEC risk factors for NAII?

Per NAII's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0000787253), Natural Alternatives International Inc. generated $129.9M in revenue (+14.1% YoY), -$13.6M in net income, and $2.3M in free cash flow against $153.3M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is NAII trading relative to its 50-day, 200-day, and 52-week technical levels?

NAII last traded at $1.11 (-4.31% on volume of 38,016 shares), positioning the stock -31.90% below its 50-day simple moving average ($1.63) and -54.69% below its 200-day simple moving average ($2.45). Across its 52-week range of $1.07 to $4.96, NAII sits at the 1.0% percentile with a 14-day RSI of 25.4 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.00 to $1.25).

NAII Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

When is NAII's next earnings date?

Based on SEC filing cadence, Natural Alternatives International Inc. (NAII)'s next quarterly reporting window is estimated around Dec 28, 2026.

How much is NAII stock expected to move on earnings?

Volatility modeling currently projects a ±12.5% event move for NAII, spanning a range between $1 and $1.25.

Direct Sub-Reports: NAII RQD Cockpit NAII 12M Forecast NAII Earnings & Move NAII Dividends & DRIP NAII Insiders & 13F NAII Whale Options NAII Profit Sankey NAII News & Why